risperidone has been researched along with methamphetamine in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (13.04) | 18.2507 |
| 2000's | 11 (47.83) | 29.6817 |
| 2010's | 8 (34.78) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Furukawa, H; Hasegawa, T; Kitaichi, K; Nabeshima, T; Ogita, K; Yamada, K; Yoneda, Y | 1 |
| Kofoed, L; Misra, L | 1 |
| Iyo, M; Matsunaga, T; Mori, N; Sekine, Y; Takei, N; Tsukamoto, T | 1 |
| Kofoed, L; Misra, LK; Oesterheld, JR; Richards, GA | 1 |
| Chaki, S; Funakoshi, T; Kameo, K; Kawashima, N; Okuyama, S; Omura, T | 1 |
| Kraemer, T; Kratzsch, C; Maurer, HH; Peters, FT; Weber, AA | 1 |
| Chaki, S; Funakoshi, T; Goto, M; Kameo, K; Kawashima, N; Kumagai, T; Nakazato, A; Okuyama, S; Suzuki, Y; Yoshikawa, R | 1 |
| de Wit, H; Ortengren, A; Wachtel, SR | 1 |
| Matsuoka, N; Mutoh, S; Shirakawa, K; Tada, M | 1 |
| Cherrier, M; Jaffe, C; Meredith, CW; Saxon, AJ; Yanasak, E | 1 |
| Inada, T; Oda, T; Yamamoto, N | 1 |
| Abekawa, T; Ito, K; Koyama, T; Nakagawa, S; Nakato, Y | 1 |
| Avila, M; Bae, S; Chen, LA; Djokovic, M; Kaiser, K; Nejtek, VA; Podawiltz, A; Rush, AJ; Zielinski, T | 1 |
| Abe, Y; Hirokawa, S; Kakita, A; Kato, T; Kominami, R; Nawa, H; Ozaki, M; Sotoyama, H; Takahashi, H | 1 |
| Kato, S; Nisijima, K; Shioda, K; Yoshino, T | 1 |
| Correll, CU; Iwata, N; Kishi, T; Matsuda, Y | 1 |
| Banks, ML; Blough, BE | 1 |
| Banks, ML; Blough, BE; Smith, DA | 1 |
| Likhitsathian, S; Maneeton, B; Maneeton, N; Oon-Arom, A; Srisurapanont, M; Suradom, C; Suttajit, S | 1 |
3 review(s) available for risperidone and methamphetamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.
Topics: Amphetamine-Related Disorders; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Central Nervous System Stimulants; Cocaine; Cocaine-Related Disorders; Dopamine; Dopamine Uptake Inhibitors; Humans; Methamphetamine; Olanzapine; Outcome Assessment, Health Care; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Substance Withdrawal Syndrome; Synaptic Transmission; Treatment Outcome | 2013 |
Efficacy and dropout rates of antipsychotic medications for methamphetamine psychosis: A systematic review and network meta-analysis.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Haloperidol; Humans; Methamphetamine; Network Meta-Analysis; Olanzapine; Patient Dropouts; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia | 2021 |
3 trial(s) available for risperidone and methamphetamine
| Article | Year |
|---|---|
The effects of acute haloperidol or risperidone on subjective responses to methamphetamine in healthy volunteers.
Topics: Adolescent; Adult; Affect; Central Nervous System Stimulants; Dopamine; Dopamine Antagonists; Double-Blind Method; Emotions; Female; Haloperidol; Humans; Male; Methamphetamine; Risperidone; Serotonin; Serotonin Antagonists | 2002 |
An open-label pilot study of risperidone in the treatment of methamphetamine dependence.
Topics: Adult; Amphetamine-Related Disorders; Antipsychotic Agents; Central Nervous System Stimulants; Female; Humans; Male; Methamphetamine; Middle Aged; Neuropsychological Tests; Pilot Projects; Psychiatric Status Rating Scales; Risperidone; Substance Withdrawal Syndrome; United States; Veterans | 2007 |
Do atypical antipsychotics effectively treat co-occurring bipolar disorder and stimulant dependence? A randomized, double-blind trial.
Topics: Adult; Amphetamine-Related Disorders; Antipsychotic Agents; Bipolar Disorder; Cocaine-Related Disorders; Comorbidity; Demography; Diagnostic and Statistical Manual of Mental Disorders; Dibenzothiazepines; Double-Blind Method; Electrocardiography; Female; Humans; Male; Methamphetamine; Middle Aged; Quetiapine Fumarate; Risperidone | 2008 |
17 other study(ies) available for risperidone and methamphetamine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Risperidone prevents the development of supersensitivity, but not tolerance, to phencyclidine in rats treated with subacute phencyclidine.
Topics: Animals; Antipsychotic Agents; Dizocilpine Maleate; Drug Tolerance; Haloperidol; Isoxazoles; Male; Methamphetamine; Motor Activity; Phencyclidine; Piperidines; Rats; Rats, Wistar; Receptors, Phencyclidine; Receptors, Serotonin; Risperidone; Ritanserin | 1995 |
Risperidone treatment of methamphetamine psychosis.
Topics: Drug Administration Schedule; Humans; Male; Methamphetamine; Middle Aged; Psychoses, Substance-Induced; Risperidone; Substance-Related Disorders | 1997 |
Methamphetamine-associated obsessional symptoms and effective risperidone treatment: a case report.
Topics: Adult; Dopamine Antagonists; Humans; Male; Methamphetamine; Obsessive-Compulsive Disorder; Psychoses, Substance-Induced; Risperidone; Serotonin Antagonists; Substance-Related Disorders | 1999 |
Olanzapine treatment of methamphetamine psychosis.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Central Nervous System Stimulants; Humans; Male; Methamphetamine; Olanzapine; Pirenzepine; Psychoses, Substance-Induced; Risperidone | 2000 |
Neuropharmacological profiles of a novel atypical antipsychotic, NRA0562, in rats.
Topics: Action Potentials; Animals; Antipsychotic Agents; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Immunohistochemistry; Male; Methamphetamine; Neurons; Piperidines; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Risperidone; Thiazoles | 2001 |
Negative ion chemical ionization gas chromatography-mass spectrometry and atmospheric pressure chemical ionization liquid chromatography-mass spectrometry of low-dosed and/or polar drugs in plasma.
Topics: Amphetamine; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Central Nervous System Stimulants; Chemical Phenomena; Chemistry, Physical; Chromatography, High Pressure Liquid; Drug Monitoring; Gas Chromatography-Mass Spectrometry; Humans; Indicators and Reagents; Methamphetamine; Pharmaceutical Preparations; Poisons; Risperidone; Spectrometry, Mass, Electrospray Ionization; Stereoisomerism | 2002 |
In vitro and in vivo pharmacological profile of 5-[2-[4-(6-fluoro-1H-indole-3-yl)piperidin-1-yl]ethyl]-4-(4-fluorophenyl)thiazole-2-carboxylic acid amide (NRA0562), a novel and putative atypical antipsychotic.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Catalepsy; Central Nervous System Stimulants; Clozapine; Humans; Male; Methamphetamine; Motor Activity; Piperidines; Rats; Receptor, Serotonin, 5-HT2A; Receptors, Adrenergic, alpha-1; Receptors, Dopamine; Receptors, Drug; Receptors, Serotonin; Risperidone; Stereotyped Behavior; Thiazoles | 2002 |
Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Administration, Oral; Animals; Antipsychotic Agents; Basal Ganglia Diseases; Catalepsy; Chlorpromazine; Dibenzothiazepines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Haloperidol; Hyperkinesis; Injections, Intraperitoneal; Male; Methamphetamine; Mice; Piperazines; Pyridines; Quetiapine Fumarate; Receptor, Serotonin, 5-HT1A; Risperidone; Schizophrenia; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists | 2004 |
Methamphetamine psychosis in which tardive dystonia was successfully treated with clonazepam.
Topics: Aged; Anti-Dyskinesia Agents; Antipsychotic Agents; Benzodiazepines; Biperiden; Central Nervous System Stimulants; Clonazepam; Dyskinesia, Drug-Induced; Hallucinations; Haloperidol; Humans; Male; Methamphetamine; Olanzapine; Posture; Psychoses, Substance-Induced; Risperidone | 2007 |
Olanzapine and risperidone block a high dose of methamphetamine-induced schizophrenia-like behavioral abnormalities and accompanied apoptosis in the medial prefrontal cortex.
Topics: Animals; Antipsychotic Agents; Apoptosis; Behavior, Animal; Benzodiazepines; Disease Models, Animal; Dizocilpine Maleate; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Glutamic Acid; In Situ Nick-End Labeling; Male; Methamphetamine; Motor Activity; Neural Inhibition; Neuroprotective Agents; Olanzapine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Risperidone; Schizophrenia; Time Factors | 2008 |
Transient exposure of neonatal mice to neuregulin-1 results in hyperdopaminergic states in adulthood: implication in neurodevelopmental hypothesis for schizophrenia.
Topics: Acoustic Stimulation; Animals; Animals, Newborn; Behavior, Animal; Biotinylation; Brain; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Gene Expression Regulation, Developmental; Hearing; Immunoprecipitation; Levodopa; Locomotion; Methamphetamine; Mice; Microdialysis; Neuregulin-1; Phosphorylation; Potassium; Proto-Oncogene Proteins c-fos; Reflex, Startle; Risperidone; Social Behavior; Statistics, Nonparametric; Tyrosine 3-Monooxygenase | 2011 |
Effect of risperidone on acute methamphetamine-induced hyperthermia in rats.
Topics: Acute Disease; Animals; Chronic Disease; Fever; Male; Methamphetamine; Rats; Rats, Wistar; Risperidone | 2010 |
Effects of Environmental Manipulations and Treatment with Bupropion and Risperidone on Choice between Methamphetamine and Food in Rhesus Monkeys.
Topics: Animals; Bupropion; Choice Behavior; Conditioning, Operant; Dopamine Agents; Environment; Food; Macaca mulatta; Male; Methamphetamine; Risperidone; Self Administration | 2015 |
Methamphetamine-like discriminative stimulus effects of bupropion and its two hydroxy metabolites in male rhesus monkeys.
Topics: Animals; Antidepressive Agents, Second-Generation; Bupropion; Central Nervous System Stimulants; Conditioning, Operant; Discrimination Learning; Dopamine Antagonists; Dose-Response Relationship, Drug; Macaca mulatta; Male; Methamphetamine; Nicotine; Nicotinic Agonists; Reinforcement, Psychology; Risperidone; Time Factors; Varenicline | 2016 |